Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ensysce Biosciences, Inc. (LACQ) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ensysce Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1716947.
Total stock buying since 2017: $10,774,777.
Total stock sales since 2017: $0.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 469,587 | $226,458 | 0 | $0 | 0 | $0 |
| 2022 | 454,143 | $548,319 | 0 | $0 | 0 | $0 |
| 2020 | 0 | $0 | 776,290 | $0 | 0 | $0 |
| 2017 | 1,000,000 | $10,000,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-03 | 360,287 | $173,120 | 0 | $0 | 0 | $0 |
| 2023-02 | 109,300 | $53,338 | 0 | $0 | 0 | $0 |
| 2022-12 | 357,143 | $500,000 | 0 | $0 | 0 | $0 |
| 2022-05 | 97,000 | $48,319 | 0 | $0 | 0 | $0 |
| 2020-06 | 0 | $0 | 776,290 | $0 | 0 | $0 |
| 2017-12 | 1,000,000 | $10,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-02 | Gower Bob G | Buy | 90,287 | .49 | 44,060 |
| 2023-03-01 | Gower Bob G | Buy | 270,000 | .48 | 129,060 |
| 2023-02-28 | Gower Bob G | Buy | 109,300 | .49 | 53,338 |
| 2022-12-09 | Gower Bob G | Buy | 357,143 | 1.40 | 500,000 |
| 2022-05-26 | Kirkpatrick Lynn (Chief Executive Officer) | Buy | 27,000 | .53 | 14,229 |
| 2022-05-25 | Kirkpatrick Lynn (Chief Executive Officer) | Buy | 70,000 | .49 | 34,090 |
| 2020-06-19 | Morgan Stanley (10% Owner) | Sale | 776,290 | .00 | 0 |
| 2017-12-01 | Hg Vora Capital Management, Llc | Buy | 1,000,000 | 10.00 | 10,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of LACQ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ensysce Biosciences, Inc. (symbol LACQ, CIK number 1716947) see the Securities and Exchange Commission (SEC) website.